Other

ROU Asset Obtained - Finance Lease

West Pharmaceutical Services ROU Asset Obtained - Finance Lease decreased by 71.4% to $200.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 84.6%, from $1.30M to $200.00K.

Analysis

StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ2 2023
Last reportedQ1 2026Apr 23, 2026

How to read this metric

Significant additions indicate capital-intensive growth or modernization efforts funded via leasing.

Detailed definition

This is a non-cash metric representing the initial recognition of right-of-use assets resulting from new finance lease a...

Peer comparison

Comparable across industries that rely on leasing for heavy equipment or infrastructure.

Metric ID: cvx_rou_asset_obtained_finance_lease

Historical Data

8 periods
 Q2 '23Q3 '23Q1 '24Q2 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$0.00$0.00$0.00$24.30M$1.30M$900.00K$700.00K$200.00K
QoQ Change-94.7%-30.8%-22.2%-71.4%
YoY Change-96.3%-84.6%
Range$0.00$24.30M
Avg YoY Growth-90.5%
Median YoY Growth-90.5%
Current Streak4+ quarters decline

Frequently Asked Questions

What is West Pharmaceutical Services's rou asset obtained - finance lease?
West Pharmaceutical Services (WST) reported rou asset obtained - finance lease of $200.00K in Q1 2026.
How has West Pharmaceutical Services's rou asset obtained - finance lease changed year-over-year?
West Pharmaceutical Services's rou asset obtained - finance lease decreased by 84.6% year-over-year, from $1.30M to $200.00K.
What does rou asset obtained - finance lease mean?
The value of new assets acquired through finance leases.